Clinical Advances in Nasopharyngeal Carcinoma - Episode 9
Victoria M. Villaflor, MD, discusses the integration of PD-1 inhibitors into standard treatment practices for patients with nasopharyngeal carcinoma.
Video content above is prompted by the following:
What are the potential benefits of integrating PD-1 inhibitors into standard treatment protocols for NPC?